NCT00230308
Recruiting
Not Applicable
Identification and Characterization of Novel Proteins and Genes in Head and Neck Cancer
ConditionsHead and Neck Cancer
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Head and Neck Cancer
- Sponsor
- Stanford University
- Enrollment
- 500
- Locations
- 1
- Status
- Recruiting
- Last Updated
- 4 months ago
Overview
Brief Summary
Through this study, we hope to learn more about the mechanisms, which may contribute to development and progression of head and neck cancer. The long-term goal of this study will be to develop new strategies and drugs for the diagnosis and treatment of head and neck cancer.
Investigators
Eligibility Criteria
Inclusion Criteria
- •All patients undergoing surgery at Stanford University for head and neck cancer.
Exclusion Criteria
- •Non-Stanford patients.
Outcomes
Primary Outcomes
Not specified
Study Sites (1)
Loading locations...
Similar Trials
Terminated
Not Applicable
Identification and Characterization of Molecular Markers in Musculoskeletal TumorsSoft Tissue and Bone TumorsSarcomaSarcoma of BoneSoft Tissue SarcomaNCT02199938Balgrist University Hospital50
Recruiting
Not Applicable
Identification of New Biological Markers for the Progression of Mycobacterium Abscessus-induced Lung Disease in Cystic FibrosisNon-Tuberculous Mycobacterial PneumoniaCystic Fibrosis LungNCT06413459Ospedale San Raffaele40
Active, not recruiting
Not Applicable
Identification of Novel Skeletal Muscle-derived Factors That Promote Lipid Oxidation (Columbus)ObesityDisorder of Lipid Storage and MetabolismLipid Metabolism DisordersMetabolic DisorderNCT01911091AdventHealth Translational Research Institute56
Completed
Not Applicable
Insight Into New Brown Adipose Tissue Activators.AdiposityMetabolic ComplicationMetabolic DisturbanceHealthyObesityDiet HabitNutritional and Metabolic DiseasesNCT04787952Medical University of Bialystok40
Active, not recruiting
Not Applicable
Immune and Genomic Markers in ALK+ NSCLCAnaplastic Lymphoma Kinase Gene TranslocationNon-Small Cell Lung CancerNCT04881916Massachusetts General Hospital100